2016
DOI: 10.1007/s00125-016-4097-y
|View full text |Cite
|
Sign up to set email alerts
|

The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice

Abstract: Aims/hypothesis Despite the strong correlation between nonalcoholic fatty liver disease and insulin resistance, hepatic steatosis is associated with greater whole-body insulin sensitivity in several models. We previously reported that the inhibition of hepatic glucose production (HGP) protects against the development of obesity and diabetes despite severe steatosis, thanks to the secretion of specific hepatokines such as fibroblast growth factor 21 (FGF21) and angiopoietinrelated growth factor. In this work, w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 52 publications
(76 reference statements)
0
7
0
Order By: Relevance
“…Several studies have suggested that improved glucose and insulin tolerance is associated with the inhibition of hepatic glucose production. 36 , 37 , 38 These, together with the improved glucose, insulin, and leptin levels in the FA-treated group, led us to hypothesize that FA might reduce hepatic glucose production in HFD-induced obese mice. To address this question, we examined the expression of the rate limiting enzymes for gluconeogenesis, PEPCK and G6P.…”
Section: Resultsmentioning
confidence: 99%
“…Several studies have suggested that improved glucose and insulin tolerance is associated with the inhibition of hepatic glucose production. 36 , 37 , 38 These, together with the improved glucose, insulin, and leptin levels in the FA-treated group, led us to hypothesize that FA might reduce hepatic glucose production in HFD-induced obese mice. To address this question, we examined the expression of the rate limiting enzymes for gluconeogenesis, PEPCK and G6P.…”
Section: Resultsmentioning
confidence: 99%
“…FGF21 is a pleiotropic secretion protein, which possesses multiple metabolic benefits including ameliorating insulin resistance, improving hepatic lipid accumulation, and extending lifespan [ 24 , 40 42 ]. In the past decades, the bulk of scientific research focused on the mechanism of FGF21 regulating glucose and lipid metabolism in obesity and diabetes.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, the quality and quantity of VAT play significant roles in adipocyte function and are related to insulin resistance [33]. It was also concluded about the existence of a strong correlation between glucose production and insulin sensitivity in SAT [34].…”
Section: Introductionmentioning
confidence: 99%